Oral Typhoid Vaccine Market: Increasing Investments in Healthcare Sector of the Country to Boost Growth | Sanofi Pasteur, Bharat Biotech, Pfizer Inc

The Oral Typhoid Vaccine Market is estimated for 2023 for the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:

The oral typhoid vaccine market involves vaccines that are given orally to prevent typhoid fever caused by Salmonella Typhi bacteria. These live attenuated vaccines help induce immunogenic response against the pathogen.

Market Dynamics:

The oral typhoid vaccine market is driven by rising immunization programs across developing and underdeveloped nations. The World Health Organization (WHO) recommends vaccination against typhoid fever in endemic areas. Furthermore, the launch of novel typhoid vaccines such as BioFarma's Typbar-TCV vaccine is also fueling market growth. Typbar-TCV demonstrated higher efficacy compared to existing vaccines in phase 3 clinical trials. It has received regulatory approvals in several countries including India and has attracted funding for mass vaccination programs. Moreover, rising awareness regarding hygiene and sanitation is reducing disease incidence aiding the preventative oral typhoid vaccines market.

Receive Free Sample of Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/6332

** Note - This Report Sample Includes:

‣ Brief Overview to the research study.

‣ Table of Contents The scope of the study's coverage

‣ Leading market participants

‣ Structure of the report's research framework

‣ Coherent Market Insights' research approach

Major companies in Oral Typhoid Vaccine Market are:

✤ Sanofi Pasteur
✤ Bharat Biotech
✤ Pfizer Inc.
✤ GlaxoSmithKline (GSK)
✤ Baxter International Inc.
✤ Merck & Co. Inc. (MSD outside North America)
✤ Takeda Pharmaceutical Company Limited
✤ Novartis International AG
✤ Biological E. Limited
✤ AstraZeneca
✤ Cipla Limited
✤ Prokarium
✤ Bio-Med Pvt. Ltd.
✤ Panacea Biotec
✤ Dynavax Technologies Corporation
✤ Butantan Institute
✤ Zydus Cadila
✤ Biomed Pvt. Ltd.
✤ Cadila Healthcare Limited
✤ GlaxoSmithKline Biologicals

Note: Major Players are sorted in no particular order.

Oral Typhoid Vaccine Market Drivers

Increasing Initiatives by Governments and International Organizations to Curb Typhoid Prevalence

Governments across various countries are focusing on expanding vaccination programs and undertaking various public awareness initiatives to curb the spread of typhoid. International organizations like WHO are also supporting national typhoid control programs through partnership and funding. For instance, multi-country initiatives like Global Typhoid Vaccine Introduction working group aims to support at least 20 countries to introduce prequalified oral typhoid vaccines by 2025. Such continued efforts by public as well as international bodies are creating widespread awareness and increasing demand for oral typhoid vaccines.

Growing Adoption of Oral Typhoid Vaccines Over Injectable Variants

Traditionally, injectable Vi capsular polysaccharide vaccine was the only licensed vaccine for preventing typhoid. However, oral typhoid vaccines offer various advantages over injectable variants including ease of administration without requirement of trained healthcare professionals. This enables better reach and higher vaccination rates. Furthermore, oral vaccines have shown to provide longer lasting protection compared to injectable Vi vaccine. Considering these benefits, oral typhoid vaccines are increasingly becoming the preferred choice and getting adopted at a higher rate globally. This growing preference shift is driving significant growth in the oral typhoid vaccine market.

Oral Typhoid Vaccine Market Restrain

High Cost of Vaccine Development

Developing new vaccines requires huge financial investments in various stages including research, clinical trials, registration & licensing. Typhoid also affects mostly low and middle income countries where governments have limited healthcare budgets. This creates challenges in securing necessary funding for vaccine development programs. Additionally, oral typhoid vaccines need to undergo lengthy and costly clinical evaluation due to administration through oral route instead of injection. The high costs associated with vaccine R&D act as a major bottleneck in development of novel and improved oral typhoid vaccines.

Oral Typhoid Vaccine Market Opportunity

Increasing Investments in Emerging Countries

Earlier, most vaccine manufacturers focused on developed regions with strong markets. However, growing economies in Asia Pacific and Latin America are now witnessing substantial increase in per capita healthcare spends. This has prompted companies to look at emerging countries as focal markets. For instance, emerging countries like India and China are prioritizing typhoid control through vaccination programs. Additionally, international healthcare foundations are also supporting vaccine access in low and middle income settings through financing. The increasing investments in healthcare infrastructure and immunization programs in developing regions present lucrative opportunities for oral typhoid vaccine manufacturers to tap new revenue streams.

Oral Typhoid Vaccine Market Trends

Rising Focus on Developing Quadrivalent Vaccines

Currently marketed oral typhoid vaccines provide protection against only Salmonella Typhi bacteria which causes typhoid fever. However, there is a growing need to expand protection to other drug-resistant non-typhoid Salmonella (NTS) serovars which are also becoming a major public health issue in some regions. As a result, leading players are investing in R&D for oral typhoid vaccines that can offer broader protection against four Salmonella serovars including Typhi, Paratyphi A, Paratyphi B, and Paratyphi C. The development of quadrivalent oral typhoid vaccines could open up broader market potential. The rising focus on quadrivalent vaccines is a notable trend that is expected to significantly impact future landscape of the oral typhoid vaccine market.

Purchase Our Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/6332

Highlights of the global Oral Typhoid Vaccine Market report:

→ This analysis provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2023-2030), using 2021 as the base year. It also covers the global Oral Typhoid Vaccine Market in-depth.

→ It offers enticing investment proposition matrices for this sector and explains the likely future growth of key revenue streams.

→ Additionally, this study offers crucial insights into market forces, limitations, opportunities, new product introductions or approvals, market trends, regional perspective, and competitive tactics used by top rivals.

→ Based on the following factors: company highlights, product portfolio, significant highlights, financial performance, and strategies, it covers key players in the global Oral Typhoid Vaccine Market.

→ Marketers and company leaders will be able to make wise decisions about next product launches, type updates, market expansion, and marketing strategies thanks to the insights from this research.

→ A wide spectrum of industry stakeholders are covered by the global Oral Typhoid Vaccine Market research, including investors, vendors, product producers, distributors, new entrants, and financial analysts.

→ The many strategy matrices used in researching the global Oral Typhoid Vaccine Market will aid stakeholders in making decisions.

The research was developed through the synthesis, analysis, and interpretation of data gathered from multiple sources on the parent market. Additionally, analysis has been done of the economic circumstances and other economic indicators and factors to evaluate their respective impact on the Oral Typhoid Vaccine Market, along with the present impact, so as to develop strategic and informed projections about the scenarios in the market. This is mostly due to the developing countries' unmet potential in terms of product pricing and revenue collection.

Key Questions Answered In The Report:

• Which regional market will experience the greatest and most rapid growth?

• Who are the top five Oral Typhoid Vaccine Market players?

• How will the Oral Typhoid Vaccine Market evolve over the next six years?

• What application and product will dominate the Oral Typhoid Vaccine Market?

• What are the market drivers and constraints for Oral Typhoid Vaccine Market?

• What will be the Oral Typhoid Vaccine Market's CAGR and size during the forecast period?

Get Customize Report! @ https://www.coherentmarketinsights.com/insight/request-customization/6332

Contact Us

Mr. Shah
Coherent Market Insights Pvt Ltd,
533 Airport Boulevard, Suite 400, Burlingame,
CA 94010, United States
Phone: US +12067016702 / UK +4402081334027
JAPAN:+81-50-5539-1737
INDIA:+91-848-285-0837
Email: sales@coherentmarketinsights.com

About Coherent Market Insights

Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.

This release was published on openPR.